REG - Thalassa Holdings - Subsidiary Prospectus and Expected Admission

Thalassa HoldingsAnnouncement

19/10/2020 18:00

RNS Number : 5369C
  
Thalassa Holdings Limited
  
19 October 2020
  
 

19 October 2020
 
 
Thalassa Holdings Ltd
(Reuters: THAL.L, Bloomberg: THAL:LN)
("Thalassa", "THAL" or the "Company")
 
and its subsidiary
 
Anemoi International Limited 
("Anemoi" or the "Subsidiary")
 
SUBSIDIARY PUBLICATION OF PROSPECTUS 
 
ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE EXPECTED ON 26 OCTOBER  2020
 
Thalassa is pleased to announce that the Prospectus for the listing of the ordinary shares ("Shares") of its subsidiary Anemoi on the Standard Segment of the Official List and the LSE's Main Market for listed securities ("Admission") has been approved by the UK Listing Authority ("UKLA") and will be posted today, 19 October 2020, on its website at ‎https://anemoi-international.com/investor-relations/company-‎documents/‎‎.
 
Application for Admission is being made to the UKLA and, subject to the UKLA's approval, Anemoi expects that Admission will become effective and that unconditional dealings in the Shares will commence at 08.00 a.m. on 26, October 2020 under the ticker "AMOI".
 
A copy of the Prospectus has been submitted to the National Storage Mechanism and is available for inspection (subject to securities laws) at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. 
 
 



Enquiries:








Anemoi International Ltd








Duncan Soukup (Chief Executive)


+33 (0)6 78 63 26 89



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCUKVNRRNURAAA